Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.

Marion BerthoJulien FraisseAnne PatsourisPaul CottuMonica ArnedosDavid PérolAnne JaffréAnthony GoncalvesMarie-Paule LebitasyVéronique D'HondtFlorence DalencJean-Marc FerreroChristelle LevySandrine DabakuyoRoman RouzierFrédérique Penault-LlorcaLionel UwerJean-Christophe EymardMathias BretonMichaël ChevrotSébastien ThureauThierry PetitGaëtane SimonJean-Sébastien Frenel

Published in: Therapeutic advances in medical oncology (2021)

BO MBC patients have better outcomes compared with non-BO MBC, consistently, through all MBC subtypes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
cross sectional
patient reported outcomes
bone mineral density
skeletal muscle
weight loss
glycemic control